Trial Profile
A phase II, single-arm study to evaluate the efficacy of DAS181 in patients with Parainfluenza virus Infection in 16 Hematopoietic Stem Cell transplant Recipients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jan 2015
Price :
$35
*
At a glance
- Drugs Oplunofusp (Primary)
- Indications Parainfluenza virus infections
- Focus Therapeutic Use
- 22 Jan 2015 New trial record